Does A Private Sale Trigger The ‘On-Sale Bar’ For Patents?
From oral arguments in this case, it’s not clear how the Supreme Court will ultimately decide.
Muddy Waters? SCOTUS, Secret Sales, And The America Invents Act
How will SCOTUS address the issue? That is anything but certain.
Why Better Financial Acumen is the Key to Law Firm Success in 2025
From training to technology, uncover the essential steps to futureproof your law firm in a competitive market.
SCOTUS Upholds Constitutionality Of System To Challenge Bad Patents
Why should a government agency not be able to correct its own mistakes?
3 Observations From The Federal Circuit Judicial Conference
The Federal Circuit will continue in its efforts to bring uniformity to patent law, and will not shy away from challenges presented by the America Invents Act.
Why Assigning Patents To Native American Tribes To Avoid Inter Partes Review Is Bad Medicine
Here are three big reasons why, according to IP columnist Tom Kulik.
A New Patent Loophole? Paying Off A Native American Tribe To Exploit Its Sovereign Immunity
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
The Hidden Threat: How Fake Identities used by Remote Employees Put Your Business at Risk—and How to Defend Against This
Based on our experience in recent client matters, we have seen an escalating threat posed by the Democratic People’s Republic of Korea (DPRK) information technology (IT) workers engaging in sophisticated schemes to evade US and UN sanctions, steal intellectual property from US companies, and/or inject ransomware into company IT environments, in support of enhancing North Korea’s illicit weapons program.
Developing The Story Of Patent Litigation: Q&A With Cooley’s Ellen Scordino
This Biglaw partner brings pharma experience to law firm cases.
Is Patent Litigation Dead? What Gives?
Is the field of IP litigation still worth getting into?